Home Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer
Article
Licensed
Unlicensed Requires Authentication

Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer

  • Stéphane Gidenne , Franck Ceppa , Eleonore Fontan , Françoise Perrier and Pascal Burnat
Published/Copyright: June 1, 2005

Abstract

Recently a new biological marker, Ischemia Modified Albumin (IMA®), measured by the Albumin Cobalt Binding (ACB®) test, was introduced for detection of myocardial ischemia. During ischemia, the metal binding capacity of albumin for certain transition metals like cobalt is reduced. The precise mechanism of action for producing IMA is not known but appears to be related to the production of reactive oxygen species that modify the metal binding sites. The ACB test is a quantitative assay that detects IMA by measuring the cobalt binding capacity of albumin in human serum. We evaluated the analytical characteristics of the ACB test, and reagent and specimen stability, using the Cobas MIRA® Plus instrument. Coefficients of variation for within-run and between-run assays were <4%. No significant interference was observed for concentrations of triglycerides and hemoglobin up to 7 mmol/l and 3.8 g/l, respectively. No interference was apparent with bilirubin. Measures from paired samples of heparinized plasma and serum were not equivalent. The assay is validated for commercial use with serum, therefore our study reported results for serum specimens only. All assays were completed within 5 hours after blood withdrawal. The one-sided upper 95th percentile, calculated for the ACB test in 150 healthy subjects, was 87.00 U/ml. There was no observed difference between men and women or with age. We conclude that the ACB test adapted on the Cobas MIRA Plus analyzer is satisfactory, but strict attention to sample handling procedures is necessary to maintain stability of the analyte.

Published Online: 2005-6-1
Published in Print: 2004-4-5

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. How useful are haematology analyser flags?
  2. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders
  3. Automated flagging influences the inconsistency and bias of band cell and atypical lymphocyte morphological differentials
  4. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport
  5. Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit
  6. Prohepcidin accumulates in renal insufficiency
  7. Impurities from polypropylene microcentrifuge tubes as a potential source of interference in simultaneous analysis of multiple lipid-soluble antioxidants by HPLC with electrochemical detection
  8. Cerebrospinal fluid tau and Aβ42 concentrations in healthy subjects: delineation of reference intervals and their limitations
  9. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers
  10. Reference change values and power functions
  11. A different approach to analyzing age-related HbA1c values in non-diabetic subjects
  12. Ratio of urinary free immunoglobulin light chain κ to λ in the diagnosis of Bence Jones proteinuria
  13. Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels
  14. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® System
  15. Comparison of three commercial assays for the measurement of 17α-hydroxyprogesterone (17α-OHPR): limitations of the quality control system
  16. Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer
  17. Letter to the Editor
  18. Meetings and Awards
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.079/html
Scroll to top button